ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,077Medicare Part D Prescriptions Filled, Including Refills

Rank: 136 out of 617

$394K Total Retail Price of All Prescriptions

Rank: 155 out of 617

450 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 450 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 8,172 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 441 412 1 1
SIMVASTATIN 429 395 2 2
POTASSIUM CHLORIDE 412 362 3 10
OMEPRAZOLE 346 292 4 3
WARFARIN SODIUM 340 301 5 7
FUROSEMIDE 252 210 6 4
METFORMIN HCL 212 177 7 9
ATENOLOL 209 187 8 17
AMLODIPINE BESYLATE 169 157 9 6
LISINOPRIL 166 148 10 5
CARVEDILOL 164 164 11 19
MELOXICAM 161 154 12 24
CITALOPRAM HBR 154 132 13 18
ZOLPIDEM TARTRATE 145 139 14 23
TAMSULOSIN HCL 137 137 15 26
ALLOPURINOL 123 112 16 27
HYDROCHLOROTHIAZIDE 109 109 17 13
METOPROLOL TARTRATE 106 87 18 11
ENALAPRIL MALEATE 104 96 19 34
NAMENDA 96 96 20 35
LOSARTAN POTASSIUM 96 95 20 22
DONEPEZIL HCL 94 94 22 30
NITROGLYCERIN PATCH 91 91 23 198
METOPROLOL SUCCINATE 90 90 24 12
LOSARTAN-HYDROCHLOROTHIAZIDE 90 89 24 46
PANTOPRAZOLE SODIUM 87 87 26 37
PRAVASTATIN SODIUM 84 69 27 21
LOVASTATIN 79 67 28 57
CLONIDINE HCL 79 79 28 55
BISOPROLOL FUMARATE 79 79 28 100
ATORVASTATIN CALCIUM 75 64 31 14
DIGOXIN 74 54 32 48
TRAMADOL HCL 74 69 32 15
CELEBREX 71 66 34 63
ALENDRONATE SODIUM 69 67 35 25
BYSTOLIC 60 56 36 64
DOXAZOSIN MESYLATE 59 47 37 79
GLIPIZIDE 59 59 37 82
HYDROCODONE-ACETAMINOPHEN 57 49 S3 39 8
GABAPENTIN 57 57 39 16
POLYETHYLENE GLYCOL 3350 55 54 41 32
NIFEDIPINE ER 54 54 42 246
MICARDIS 52 44 43 320
FLUTICASONE PROPIONATE 50 39 44 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.